Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla)1

Journal of Structural Biology

Volumn 127, Issue 3, 1999, Pages 213-223

  Kemball Cook, Geoffrey ^a   Johnson, Daniel J D ^a   Tuddenham, Edward G D ^a   Harlos, Karl ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBOXYGLUTAMIC ACID; BLOOD CLOTTING FACTOR 7A; EPIDERMAL GROWTH FACTOR; ISOLEUCINE; LYSINE; PROTEINASE;

AMINO ACID SEQUENCE; ARTICLE; BLOOD CLOTTING; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; HEMOSTASIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PURIFICATION;

EID: 0032721393     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.1999.4158     Document Type: Article

References (38)

1. Adams P. D., Pannu N. S., Read R. J., Brunger A. T. Cross-validated maximum likelihood enhances crystallographic simulated annealing refinement. Proc. Natl. Acad. Sci. USA. 94:1997;5018-5023.
2. Ashton A. W., Kemball-Cook G., Johnson D. J. D., Martin D. M. A., O'Brien D. P., Tuddenham E. G. D., Perkins S. J. Factor VIIa and the extracellular domains of human tissue factor form a compact complex: A study by X-ray and neutron solution scattering. FEBS Lett. 374:1995;141-146.
3. Banner D. W., D'Arcy A., Chène C., Winkler F. K., Guha A., Konigsberg W. H., Nemerson Y., Kirchhofer D. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature. 380:1996;41-46.
4. Bharadwaj D., Iino M., Kontoyianni M., Smith K. J., Foster D. C., Kisiel W. Factor VII central - A novel mutation in the catalytic domain that reduces tissue factor binding, impairs activation by factor Xa and abolishes amidolytic and coagulant activity. J. Biol. Chem. 271:1996;30685-30691.
5. Bode W., Fehlhammer H., Huber R. Crystal structure of bovine trypsinogen at 1.8 Å resolution. I. Data collection, application of Patterson search techniques and preliminary structural interpretation. J. Mol. Biol. 106:1976;325-335.
6. Brunger, A. T. 1992, X-PLOR, Version 3.1, a System for X-ray Crystallography and NMR, Yale Univ. Press, New Haven, CT.
7. Davie E. W. Biochemical and molecular aspects of the coagulation cascade. Thromb. Haemost. 74:1995;1-6.
8. Davie E. W., Fujikawa K., Kisiel W. The coagulation cascade: Initiation, maintenance and regulation. Biochemistry. 30:1991;10363-10370.
9. Dickinson C. D., Ruf W. Active site modification of factor VIIa affects interactions of the protease domain with tissue factor. J. Biol. Chem. 272:1997;19875-19879.
10. Dickinson C. D., Shobe J., Ruf W. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa. J. Mol. Biol. 277:1998;959-971.
11. Engh A. E., Huber R. Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallogr. Sect. A. 47:1991;392-400.
12. Esnouf R. M. J. An extensively modified version of Molscript that includes greatly enhanced colouring capabilities. J. Mol. Graph. 15:1997;132-134.
13. Greer J. Comparative modeling methods: Application to the family of the mammalian serine proteases. Proteins. 7:1990;317-334.
14. Harlos K., Martin D. M. A., O'Brien D. P., Jones E. Y., Stuart D. I., Polikarpov I., Miller A., Tuddenham E. G. D., Boys C. W. G. Crystal structure of the extracellular region of human tissue factor. Nature. 370:1994;662-666.
15. Higashi S., Matsumoto N., Iwanaga S. Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity. J. Biol. Chem. 271:1996;26569-26574.
16. Higashi S., Nishimura H., Aita K., Iwanaga S. Identification of regions of bovine factor VII essential for binding to tissue factor. J. Biol. Chem. 269:1994;18891-18898.
17. Huber R., Bode W. Structural basis of the activation and action of trypsin. Acc. Chem. Res. 11:1978;114-122.
18. Johnson D. J. D., Nugent P. G., Tuddenham E. G. D., Harlos K., Kemball-Cook G. Crystallization and preliminary X-ray analysis of active site-inhibited human coagulation factor VIIa (des-Gla). J. Struct. Biol. 125:1999;90-93.
19. Jones A. FRODO. Methods Enzymol. 115:1985;157-171.
20. Kemball-Cook G., Garner I., Imanaka Y., Nishimura T., O'Brien D. P., Tuddenham E. G. D., McVey J. H. High-level production of human blood coagulation factors VII and XI using a new mammalian expression vector. Gene. 139:1994;275-279.
21. 100 → Arg - Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function. J. Biol. Chem. 273:1998;8516-8521.
22. Kirchhofer D., Banner D. W. Molecular and structural advances in tissue factor-dependent coagulation. Trends Cardiovasc. Med. 7:1997;316-324.
23. Kraulis P. J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946-950.
24. McCallum C. D., Hapak R. C., Neuenschwander P. F., Morrissey J. H., Johnson A. E. The location of the active site of blood coagulation factor VIIa above the membrane surface and its reorientation upon association with tissue factor - A fluorescence energy transfer study. J. Biol. Chem. 271:1996;28168-28175.
25. McCallum C. D., Su B. X., Neuenschwander P. F., Morrissey J. H., Johnson A. E. Tissue factor positions and maintains the factor VIIa active site far above the membrane surface even in the absence of the factor VIIa Gla domain - A fluorescence resonance energy transfer study. J. Biol. Chem. 272:1997;30160-30166.
26. Merritt E. A., Murphy M. E. P. Raster3D version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr. Sect. D. 50:1994;869-873.
27. Muller Y. A., Ultsch M. H., Kelley R. F., De Vos A. M. Structure of the extracellular domain of human tissue factor: Location of the factor VIIa binding site. Biochemistry. 33:1994;10864-10870.
28. Navaza J. AMoRe: An automated package for molecular replacement. Acta Crystallogr. Sect. D. 50:1994;157-163.
29. Nicolaisen E. M., Thim L., Jacobsen J. K., Nielsen P. F., Mollerup I., Jorgensen T., Hedner U. FVIIa derivatives obtained by autolytic and controlled cathepsin G mediated cleavage. FEBS Lett. 317:1993;245-249.
30. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Carter C. W., Sweet R. M. Macromolecular Crystallography Part A. 1997;307-326 Academic Press, London.
31. Padmanabhan K., Padmanabhan K. P., Tulinsky A., Park C. H., Bode W., Huber R., Blankenship D. T., Cardin A. D., Kisiel W. Structure of human des(1-45) factor Xa at 2.2 Å resolution. J. Mol. Biol. 232:1993;947-966.
32. Payne M. A., Neuenschwander P. F., Johnson A. E., Morrissey J. H. Effect of soluble tissue factor on the kinetic mechanism of factor VIIa: Enhancement of p-guanidinobenzoate substrate hydrolysis. Biochemistry. 35:1996;7100-7106.
33. Petersen L. C., Persson E., Freskgård P. O. Thermal effects on an enzymatically latent conformation of coagulation factor VIIa. Eur. J. Biochem. 261:1999;124-129.
34. Rapaport S. I., Rao L. V. M. The tissue factor pathway: How it has become a "prima ballerina" Thromb. Haemost. 74:1995;7-17.
35. Schechter I., Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27:1967;157-162.
36. Sorensen B. B., Persson E., Freskgård P. O., Kjalke M., Ezban M., Williams T., Rao L. V. M. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J. Biol. Chem. 272:1997;11863-11868.
37. Spraggon G., Phillips C., Nowak U. K., Ponting C. P., Saunders D., Dobson C. M., Stuart D. I., Jones E. Y. The crystal structure of the catalytic domain of human urokinase-type plasminogen activator. Structure. 3:1995;681-691.
38. Wang D., Bode W., Huber R. Bovine chymotrypsinogen A. X-ray crystal structure analysis and refinement of a new crystal form at 1.8 Å resolution. J. Mol. Biol. 185:1985;595-624.